Access

Article


Nature Medicine 12, 1301 - 1309 (2006)
Published online: 15 October 2006 | doi:10.1038/nm1492

Interleukin-10 determines viral clearance or persistence in vivo

David G Brooks1, Matthew J Trifilo1, Kurt H Edelmann1, Luc Teyton2, Dorian B McGavern1,3 & Michael B A Oldstone1,4


Persistent viral infections are a major health concern. One obstacle inhibiting the clearance of persistent infections is functional inactivation of antiviral T cells. Although such immunosuppression occurs rapidly after infection, the mechanisms that induce the loss of T-cell activity and promote viral persistence are unknown. Herein we document that persistent viral infection in mice results in a significant upregulation of interleukin (IL)-10 by antigen-presenting cells, leading to impaired T-cell responses. Genetic removal of Il10 resulted in the maintenance of robust effector T-cell responses, the rapid elimination of virus and the development of antiviral memory T-cell responses. Therapeutic administration of an antibody that blocks the IL-10 receptor restored T-cell function and eliminated viral infection. Thus, we identify a single molecule that directly induces immunosuppression leading to viral persistence and demonstrate that a therapy to neutralize IL-10 results in T-cell recovery and the prevention of viral persistence.


MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Research Highlights

Nature Biotechnology News and Views (01 Nov 2006)

CD4 + T cells: The great escape

Nature Medicine News and Views (01 Jul 2001)

See all 11 matches for News And Views